Literature DB >> 7615519

Identification of phenylalanine 346 in the rat growth hormone receptor as being critical for ligand-mediated internalization and down-regulation.

G Allevato1, N Billestrup, L Goujon, E D Galsgaard, G Norstedt, M C Postel-Vinay, P A Kelly, J H Nielsen.   

Abstract

The functional significance of growth hormone (GH) receptor (GHR) internalization is unknown; therefore, we have analyzed domains and individual amino acids in the cytoplasmic region of the rat GHR required for ligand-mediated receptor internalization, receptor down-regulation, and transcriptional signaling. When various mutated GHR cDNAs were transfected stably into Chinese hamster ovary cells or transiently into monkey kidney (COS-7) cells, internalization of the GHR was found to be dependent upon a domain located between amino acids 318 and 380. Mutational analysis of aromatic residues in this domain revealed that phenylalanine 346 is required for internalization. Receptor down-regulation in transiently transfected COS-7 cells was also dependent upon the phenylalanine 346 residue of the GHR, since no GH-induced down-regulation was observed in cells expressing the F346A GHR mutant. In contrast, the ability to stimulate transcription of the serine protease inhibitor 2.1 promoter by the GHR was not affected by the phenylalanine 346 to alanine mutation. These results demonstrate that phenylalanine 346 is essential for GHR internalization and down-regulation but not for transcriptional signaling, suggesting that ligand-mediated endocytosis is not a prerequisite for GH-induced gene transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615519     DOI: 10.1074/jbc.270.29.17210

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.

Authors:  Feida Li; Yong Li; Huan Liu; Xingju Zhang; Chuxin Liu; Kai Tian; Lars Bolund; Hongwei Dou; Wenxian Yang; Huanming Yang; Nicklas Heine Staunstrup; Yutao Du
Journal:  Transgenic Res       Date:  2015-10-28       Impact factor: 2.788

2.  Expression of growth hormone receptor and its mRNA in hepatic cirrhosis.

Authors:  Hong-Tao Wang; Shuang Chen; Jie Wang; Qing-Jia Ou; Chao Liu; Shu-Sen Zheng; Mei-Hai Deng; Xiao-Ping Liu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  βTrCP controls GH receptor degradation via two different motifs.

Authors:  Ana C da Silva Almeida; Ger J Strous; Agnes G S H van Rossum
Journal:  Mol Endocrinol       Date:  2011-10-27

4.  Binding and signalling properties of a growth hormone enhancing monoclonal antibody.

Authors:  J Beattie; S Bramani; C Secchi; J Mockridge
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

5.  The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor.

Authors:  G J Strous; P van Kerkhof; R Govers; A Ciechanover; A L Schwartz
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

6.  SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells.

Authors:  Timothy M Piazza; Juu-Chin Lu; Kristopher C Carver; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2008-12-04

Review 7.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

8.  Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor.

Authors:  R Govers; T ten Broeke; P van Kerkhof; A L Schwartz; G J Strous
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

9.  Expression of a glycosylphosphatidylinositol-anchored ligand, growth hormone, blocks receptor signalling.

Authors:  François Guesdon; Yahia Kaabi; Aiden H Riley; Ian R Wilkinson; Colin Gray; David C James; Peter J Artymiuk; Jon R Sayers; Richard J Ross
Journal:  Biosci Rep       Date:  2012-12       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.